PharmiWeb.com - Global Pharma News & Resources
30-Sep-2019

Xlife Sciences AG: Listing at Munich stock exchange


DGAP-Media / 30.09.2019 / 10:33

Zurich, September 30, 2019

Xlife Sciences AG shares are listed at Munich stock exchange as of today. The company chose the market m:access with a focus on financing of small and medium size enterprises. Currently, Xlife Sciences AG shares are traded at a share price of EUR 28.50.

The regional capital Munich offers location advantages for the company and is regarded as the leading biotechnology location in Germany and enjoys a top-notch position in Europe. The location is in particular benefiting from a close networking between academic research and the biotech industry. The majority of biotech companies are spin-offs from scientific institutions. In Munich there have been around 40 start-ups as spin-offs from scientific institutions over the last five years.



End of Media Release


Issuer: Xlife Sciences AG
Key word(s): Finance

30.09.2019 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Xlife Sciences AG
Gartenstrasse 33
8002 Z├╝rich
Switzerland
Phone: 0041 44 385 84 60
E-mail: info@xlifesciences.ch
Internet: www.xlifesciences.ch
ISIN: CH0461929603
Listed: Regulated Unofficial Market in Munich
EQS News ID: 882301

 
End of News DGAP Media

Editor Details

Last Updated: 03-Oct-2019